Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.

Literature DB >> 26063723

Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.

M Lindsay Grayson¹, Nenad Macesic², Janine Trevillyan³, Andrew G Ellis⁴, Phillip T Zeglinski⁵, Nicholas H Hewitt², Bradley J Gardiner², Albert G Frauman⁴.

Abstract

Treatment options for prostatitis caused by multidrug-resistant gram-negative bacilli are limited. We report two cases cured with oral fosfomycin and provide a pharmacokinetic analysis of fosfomycin predose concentrations during treatment.

Entities: Chemical Disease Species

Keywords: fosfomycin; microbial drug resistance; pharmacology; prostatitis

Mesh：

Substances：

Year: 2015 PMID： 26063723 DOI： 10.1093/cid/civ436

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

Keyword Cloud
Cited

19 in total

1. Ex Vivo Urinary Bactericidal Activity and Urinary Pharmacodynamics of Fosfomycin after Two Repeated Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects.

Authors: E Wenzler; K M Meyer; S C Bleasdale; M Sikka; R E Mendes; K L Bunnell; M Finnemeyer; S L Rosenkranz; L H Danziger; K A Rodvold
Journal: Antimicrob Agents Chemother Date: 2020-01-27 Impact factor: 5.191

Review 2. Fosfomycin: Resurgence of an old companion.

Authors: Sangeeta Sastry; Yohei Doi
Journal: J Infect Chemother Date: 2016-02-28 Impact factor: 2.211

3. Utility of fosfomycin as antibacterial prophylaxis in patients with hematologic malignancies.

Authors: Tanya Zapolskaya; Sarah Perreault; Dayna McManus; Jeffrey E Topal
Journal: Support Care Cancer Date: 2018-01-10 Impact factor: 3.603

4. Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.

Authors: Annabelle Pourbaix; François Guérin; Charles Burdet; Laurent Massias; Françoise Chau; Vincent Cattoir; Bruno Fantin
Journal: Antimicrob Agents Chemother Date: 2019-07-25 Impact factor: 5.191

5. Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.

Authors: G Martín-Gutiérrez; F Docobo-Pérez; J Rodriguez-Beltrán; J M Rodríguez-Martínez; J Aznar; A Pascual; J Blázquez
Journal: Antimicrob Agents Chemother Date: 2017-12-21 Impact factor: 5.191

Review 6. Fosfomycin.

Authors: Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal: Clin Microbiol Rev Date: 2016-04 Impact factor: 26.132

7. Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study.

Authors: Noah Wald-Dickler; Todd C Lee; Soodtida Tangpraphaphorn; Susan M Butler-Wu; Nina Wang; Tyler Degener; Carolyn Kan; Matthew C Phillips; Edward Cho; Catherine Canamar; Paul Holtom; Brad Spellberg
Journal: Open Forum Infect Dis Date: 2021-12-23 Impact factor: 3.835

8. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.

Authors: Ibai Los-Arcos; Carles Pigrau; Dolors Rodríguez-Pardo; Nuria Fernández-Hidalgo; Antonia Andreu; Nieves Larrosa; Benito Almirante
Journal: Antimicrob Agents Chemother Date: 2015-12-14 Impact factor: 5.191

9. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.

Authors: Eric Wenzler; Susan C Bleasdale; Monica Sikka; Kristen L Bunnell; Matthew Finnemeyer; Susan L Rosenkranz; Larry H Danziger; Keith A Rodvold
Journal: Antimicrob Agents Chemother Date: 2018-07-27 Impact factor: 5.191

Review 10. Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Authors: Bradley J Gardiner; Andrew J Stewardson; Iain J Abbott; Anton Y Peleg
Journal: Aust Prescr Date: 2019-02-01